Targeting the RNA-Binding Protein QKI in Myeloid Cells Ameliorates Macrophage-Induced Renal Interstitial Fibrosis

Ruben G de Bruin1,2, Gillian Vogel2, Jurrien Prins1

  • 1Einthoven Laboratory for Experimental Vascular Medicine, Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Albinusdreef 2, C7-36, PO Box 9600, 2300RC Leiden, The Netherlands.

Epigenomes
|December 30, 2021
PubMed

Insights

Reducing QUAKING (QKI) in myeloid cells lessens kidney fibrosis. This RNA-binding protein regulates gene expression, and its inhibition may offer new therapies for kidney diseases.

Area of Science:

  • Molecular Biology
  • Renal Pathophysiology
  • Immunology

Background:

  • Monocyte-derived macrophages drive kidney fibrosis in acute and chronic kidney injury.
  • Macrophage differentiation and function are regulated by RNA-binding proteins, including QUAKING (QKI).
  • QKI influences gene expression through pre-mRNA splicing and mRNA transcript patterns.

Purpose of the Study:

  • To investigate the role of QKI in myeloid cells during kidney injury.
  • To determine if abrogating QKI expression in myeloid cells attenuates renal interstitial fibrosis.

Main Methods:

  • Utilized two mouse models: quaking viable (qk) mice and myeloid lineage-specific QKI conditional knockout (QKI mice).
  • Induced kidney injury using unilateral urethral obstruction (UUO) model.
  • Assessed macrophage infiltration, interstitial collagen deposition, and pre-mRNA splicing defects.

Main Results:

  • Abrogation of QKI in myeloid cells reduced macrophage infiltration in UUO-induced kidney injury.
  • Both qk and QKI mice exhibited significantly diminished interstitial collagen deposition and fibrosis compared to wild-type.
  • Macrophages from QKI mice displayed pre-mRNA splicing defects.

Conclusions:

  • Reduced QKI expression in myeloid lineage cells attenuates renal interstitial fibrosis.
  • QKI is a critical regulator of splicing in macrophages impacting kidney fibrosis.
  • Inhibiting QKI may represent a potential therapeutic strategy for fibrotic kidney diseases.